Joel Ranier Chamberlain, Ph.D.
Affiliations: | University of Washington, Seattle, Seattle, WA |
Area:
Gene therapy, muscular dystrophyGoogle:
"Joel Chamberlain"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| David Ross Engelke | grad student | University of Colorado, Denver | |
| David W. Russell | post-doc | University of Washington |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Course MM, Gudsnuk K, Desai N, et al. (2019) Endogenous MicroRNA Competition as a Mechanism of shRNA-Induced Cardiotoxicity. Molecular Therapy. Nucleic Acids. 19: 572-580 |
| Bengtsson NE, Hall JK, Odom GL, et al. (2017) Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nature Communications. 8: 16007 |
| Chamberlain JR, Chamberlain JS. (2017) Progress toward Gene Therapy for Duchenne Muscular Dystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Bengtsson NE, Hall JK, Odom GL, et al. (2017) Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nature Communications. 8: 14454 |
| Bengtsson NE, Hall JK, Odom GL, et al. (2016) 501. In Vivo Gene Editing for Duchenne Muscular Dystrophy Molecular Therapy. 24: S199 |
| Bisset DR, Stepniak-Konieczna EA, Zavaljevski M, et al. (2015) Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy. Human Molecular Genetics |
| Arnett AL, Konieczny P, Ramos JN, et al. (2014) Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells. Molecular Therapy. Methods & Clinical Development. 1 |
| Wei J, Chamberlain JR. (2014) Systemic RNAi delivery to the muscles of ROSA26 mice reduces lacZ expression. Plos One. 9: e102053 |
| Ng R, Banks GB, Hall JK, et al. (2012) Animal models of muscular dystrophy. Progress in Molecular Biology and Translational Science. 105: 83-111 |
| Bortolanza S, Nonis A, Sanvito F, et al. (2011) AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 2055-64 |